March 27, 2014


UCSF diabetes specialist to lead Pediatric Endocrinology Division
Dr. Stephen Gitelman to assume leadership position on July 1

February 07, 2014

Collaborating with researchers from the Gladstone Institutes in San Francisco, Matthias Hebrok, PhD,  director of the Diabetes Center at UC San Francisco, co-authored a ground-breaking study this week on reprogramming skin cells into insulin-producing pancreas cells – a major step toward finding a cure for type 1 diabet

Matthias Hebrok, Mark Anderson
January 31, 2014

This week, the California Institute for Regenerative Medicine awarded two members of the Diabetes Center at UC  San Francisco -- immunologist Mark Anderson, MD, PhD, and stem cell researcher Matthias Hebrok, PhD -- a grant to continue their breakthrough research on 

January 06, 2014

At the 14th World Congress of the International Pancreas and Islet Transplant Association (IPITA), UC San Francisco faculty presented the latest in islet transplantation, and shared exciting progress in stopping islet and tissue rejection through regulatory T cells (Tregs) and creating new sources of insulin-producing beta cells.

January 02, 2014

T1D Exchange, the first program of the new nonprofit organization Unitio, has received funding from JDRF to study the use of metformin—a drug used as first-line treatment for type 2 diabetes—in combination with standard insulin therapy in overweight adolescents with type 1 diabetes.

January 01, 2014

A recent study in non-clinically depressed adults with type 2 diabetes compared three interventions to reduce Diabetes Distress and improve self-management. All three interventions utilized varying degrees of computer-assisted self-management.

January 01, 2014

A new, phase II clinical trial is being launched to evaluate the safety and efficacy of imatinib as a novel therapy for new-onset type 1 diabetes. Imatinib, also known as Gleevec, is a successful cancer drug that previously reversed type 1 diabetes in animal models.

November 26, 2013

Discovery of EHMT1’s role has tremendous implications for battle against obesity and related metabolic disorders, including insulin resistance. Shingo Kajimura, PhD, a researcher in the Diabetes Center and a member of the Department of Cell and Tissue Biology at UC San Francisco, has identified a gene vital to the development and function of brown fat cells.

November 15, 2013

Coursera, one of the leading providers of MOOCs (or massive open online courses) is now offering a free course on diabetes taught by faculty members from throughout UCSF’s professional schools: Medicine, Nursing, Pharmacy and Dentistry. Topics include epidemiology, diabetes diagnosis, nutritional strategies for self-management, the role of insulin in managing diabetes, effects of diabetes on oral/dental health, and current research in the field.

November 01, 2013

An experimental drug that has been studied for nearly 20 years continues to show effectiveness in about half of the patients who participated in a recent phase 2 clinical trial. The drug, Teplizumab -- also known as anti CD3 -- is designed to block the advance of Type 1 Diabetes in its earliest stages. 

November 01, 2013

Mark Anderson, MD, PhD, and his colleagues have discovered a distinctive type of immune cell called an eTAC, which puts a damper on immune responses and could eventually lead to more effective treatments for autoimmune diseases including type 1 diabetes.

November 01, 2013

After years of legal and legislative challenges, the American Diabetes Association and DREDF won their battle to support California students with diabetes.  The California Supreme Court ruled that children may receive insulin from trained volunteers without having to wait for a school nurse.